Johnson & Johnson : What You Need to Know About Johnson & Johnson's 2022 Fourth-Quarter and Full-Year Earnings Report
January 24, 2023 at 07:07 am
Share
Share
Did you like reading this story? Click the heart to show your love.
expand
Today, Johnson & Johnson shared its 2022 fourth-quarter and full-year earnings report.
Since its founding in 1886, the company has grown to become one of the world's largest and most broadly based healthcare companies, with 144,000 employees across the globe working every day to help change the trajectory of health for humanity.
"Johnson & Johnson delivered solid results and demonstrated competitive growth across our business segments in 2022, while managing ongoing macroeconomic challenges," says Joe WolkJoseph J. WolkExecutive Vice President and Chief Financial Officer, Johnson & Johnson, Executive Vice President and Chief Financial Officer, Johnson & Johnson. "We are particularly proud of the pipeline and portfolio advancements in our Pharmaceutical and MedTech businesses as well as the continued progress toward the planned separation of our Consumer Health business, all of which will fortify the foundation for long-term value creation."
For more details about the company's 2022 fourth-quarter and full-year results, and to read a message from Chairman of the Board and Chief Executive Officer Joaquin DuatoJoaquin DuatoChairman of the Board and Chief Executive Officer, Johnson & Johnson, here's an infographic highlighting key stats.
Share
Did you like reading this story? Click the heart to show your love.
expand
Johnson & Johnson's 2022 Earnings
Johnson & Johnson's 2022 Earnings
Read the earnings press release, which includes fourth-quarter andfull-year financial data for 2022.
Learn more
Want to see more company earnings information? FindJohnson & Johnson's past quarterly and full-year results here.
Did you like reading this story? Click the heart to show your love.
Johnson & Johnson published this content on 24 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 January 2023 12:06:02 UTC.
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:
- pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.;
- medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals;
- consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc.
At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25).
Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
JOHNSON & JOHNSON 
